Analysis highlights the role of hydrogel properties in bioprinting processes, suggesting improvements for clinical applications.
Hydrogel materials are pivotal in bioprinting due to their biomimetic properties, high water content, and biocompatibility, which facilitate cell viability and tissue regeneration. This paper comprehensively analyzes hydrogel-based bioprinting, focusing on material classification, printing technologies, and clinical applications. Key findings reveal that natural hydrogels (e.g., gelatin, alginate, hyaluronic acid) offer superior bioactivity, while synthetic hydrogels (e.g., PEGDA) provide tunable mechanical strength and high-resolution printability. Composite hydrogels (e.g., GelMA/alginate) synergistically combine these advantages, enhancing structural fidelity and cellular support. Advanced extrusion and vat photopolymerization techniques (e.g., SLA/DLP) have achieved resolutions down to 25 m and cell viability exceeding 95%, enabled by innovations like visible-light curing and granular microgel assembly. Computational modeling and machine learning further optimize bioink formulation and printing parameters. Despite progress, clinical translation faces barriers including standardization gaps, scalability challenges, and cost constraints. Future research must prioritize dynamic, multi-stimuli-responsive "smart hydrogels" and metabolic function emulation for complex organs. This work underscores hydrogels transformative potential in regenerative medicine while outlining pathways to overcome translational hurdles.
No takes yet. Share an insight, caveat, or question.
Minghui Wang (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: